Published guidance, NICE advice and quality standards | Guidance

Showing 491 to 500 of 1532

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over	HST20	5 May 2022	5 May 2022
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas	MIB294	5 May 2022	5 May 2022
Bladder EpiCheck for detecting bladder cancer recurrence	MIB293	3 May 2022	3 May 2022
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies	TA786	27 April 2022	27 April 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable	TA787	27 April 2022	27 April 2022
Liposuction for chronic lymphoedema	IPG723	27 April 2022	27 April 2022
Epilepsies in children, young people and adults	NG217	27 April 2022	27 April 2022
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer	TA784	20 April 2022	20 April 2022
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)	TA785	20 April 2022	20 April 2022
Elosulfase alfa for treating mucopolysaccharidosis type 4A	HST19	20 April 2022	20 April 2022